Nexus Investment Management’s Biogen BIIB Stock Holding History

Nexus Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$199K	Hold	920	–	–	0.03%	44
2026 Q1	$169K	Hold	920	–	–	0.02%	44
2025 Q4	$162K	Hold	920	–	–	0.02%	46
2025 Q3	$129K	Hold	920	–	–	0.02%	48
2025 Q2	$116K	Hold	920	–	–	0.02%	51
2025 Q1	$181K	Buy	+920	New	+$132K	0.02%	49
2024 Q3	–	Sell	-920	Closed	-$213K	–	74
2024 Q2	$213K	Buy	+920	New	+$200K	0.02%	72
2024 Q1	–	Sell	-920	Closed	-$238K	–	77
2023 Q4	$238K	Hold	920	–	–	0.02%	71
2023 Q3	$236K	Buy	+920	New	+$246K	0.03%	69

Other funds holding BIIB

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ADEF

Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return

Nexus Investment Management's BIIB Position: Q2 2026 in Review

Nexus Investment Management held its Biogen (BIIB) position steady in Q2 2026 at 920 shares worth $199K. The position accounts for 0.03% of the portfolio, ranked #44.

Nexus Investment Management first reported a position in BIIB in Q3 2023 and has held it in 9 quarters since. The position peaked at $238K in Q4 2023. 405 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Nexus Investment Management held 920 shares of Biogen worth $199K as of Q2 2026.
Nexus Investment Management left its Biogen share count unchanged in Q2 2026.
Biogen made up 0.03% of Nexus Investment Management's portfolio in Q2 2026, its #44 holding.
Nexus Investment Management first reported a position in Biogen in Q3 2023 and has held it in 9 quarters since.
Nexus Investment Management's Biogen position peaked at $238K in Q4 2023.
405 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Nexus Investment Management's 13F filing for Q2 2026, filed 20 Jul 2026.